Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / ADR
-
Shares outstanding
-
55,574,229
-
Number of holders
-
169
-
Total 13F shares, excl. options
-
61,928,932
-
Shares change
-
+3,592,875
-
Total reported value, excl. options
-
$7,267,064,424
-
Value change
-
+$416,027,513
-
Put/Call ratio
-
66%
-
Number of buys
-
88
-
Number of sells
-
78
-
Price
-
$117.36
Institutional Holders of Ascendis Pharma A/S - ADR (ASND) as of Q1 2022
As of 31 Mar 2022 Ascendis Pharma A/S - ADR (ASND) had 217 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 61,928,932 shares of stock of the company.
Largest 10 holders included Artisan Partners Limited Partnership, RA CAPITAL MANAGEMENT, L.P., FMR LLC, PRICE T ROWE ASSOCIATES INC /MD/, WELLINGTON MANAGEMENT GROUP LLP, BAKER BROS. ADVISORS LP, JANUS HENDERSON GROUP PLC, WESTFIELD CAPITAL MANAGEMENT CO LP, Avoro Capital Advisors LLC, and GOLDMAN SACHS GROUP INC.
This table shows 217 institutional shareholders of the security as of 31 Mar 2022.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.